Onbrez Inhalation Capsule 300 Micrograms (Indacaterol Maleate)

Adult use

Recommended dose for adults (18 years and older): once daily, inhale one capsule of 150 micrograms of this medication using the Breezhaler (inhaler). The once daily inhalation dose of 300 micrograms of this medication showed additional clinical benefits in patients with moderate to severe chronic obstructive pulmonary disease and shortness of breath. The maximum dose is 300 micrograms once daily. This medication should be inhaled at the same time every day.

This drug is a bronchodilator and should only be used once a day. It should not be used as an emergency treatment during acute bronchospasm. Using it together with other inhalers can lead to dangerous sudden contractions of the airways, so caution is required, and if such symptoms appear, use should be discontinued immediately and alternative treatment sought. It is advisable not to use this medication in patients with asthma, as there may be an increased risk of serious side effects in asthma patients. Individuals allergic to this drug or its components, those with lactose intolerance or specific genetic metabolic disorders, should not use it. Patients with heart disease, seizure disorders, hyperthyroidism, hypokalemia, and diabetes should use this medication with caution and consult a doctor immediately if any adverse reactions occur. The most common side effects include cold symptoms, cough, headache, muscle cramps, etc., and most are mild and decrease over time. This drug may cause cardiovascular side effects such as increased heart rate or elevated blood pressure; if these symptoms occur, use should be stopped. If pregnant or breastfeeding, careful use is advised after consulting a doctor, with particular caution needed in early pregnancy. Use in children is not recommended as safety and efficacy have not been established. In case of overdose, symptoms such as increased heart rate, tremors, headache, nausea, and drowsiness may occur; medical attention should be sought immediately in such cases. This medication must only be administered through the dedicated inhaler, and capsules should not be swallowed. Store in a tightly sealed container away from air and moisture, and keep at room temperature between 1 to 30 degrees Celsius to maintain the medication's effectiveness and prevent deterioration.

Serious side effects

• Hives
• severe swelling (edema)
• chest tightness
• difficulty breathing
• paradoxical bronchospasm
• acute respiratory failure
• seizures
• confusion
• visual disturbances
• paralysis

Mild side effects

• Nasopharyngitis
• upper respiratory tract infection
• cough
• headache
• muscle spasms
• sinusitis
• dizziness
• paresthesia
• palpitations
• tachycardia

This drug must be stored in a tightly sealed container to prevent exposure to air and moisture, ideally at room temperature between 1 and 30 degrees Celsius. This storage method preserves the medication's potency and prevents degradation.

Appearance

A transparent inhalation capsule with a yellow color containing a white powder (attached to the inhaler Breezhaler)

Package unit

30 capsules (10 capsules/PTP packaging x 3)